NCT05159193 2024-02-02Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 3 Recruiting372 enrolled